The development of alfentanil.
D015760:Alfentanil; D000701:Analgesics, Opioid / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D002626:Chemistry, Pharmaceutical; D004341:Drug Evaluation; D005283:Fentanyl / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D051379:Mice; D009270:Naloxone / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011930:Reaction Time / Q000187:drug effects; D011957:Receptors, Opioid / Q000378:metabolism; D012119:Respiration / Q000187:drug effects; D013810:Therapeutic Equivalency; D013997:Time Factors
D000701:Analgesics, Opioid; D011957:Receptors, Opioid; D015760:Alfentanil; D009270:Naloxone; D005283:Fentanyl